Invenomic Capital Management’s Orion Group Holdings ORN Stock Holding History

Invenomic Capital Management’s Portfolio ORN Stock Details ORN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-237,871	Closed	-$542K	–	179
2022 Q2	$542K	Sell	237,871 -32,530	-12%	-$83.7K	0.04%	141
2022 Q1	$556K	Buy	270,401 +11,884	+5%	+$36.3K	0.06%	146
2021 Q4	$975K	Buy	258,517 +153,319	+146%	+$682K	0.21%	109
2021 Q3	$573K	Buy	105,198 +11,155	+12%	+$61.1K	0.19%	101
2021 Q2	$541K	Buy	94,043 +34,901	+59%	+$203K	0.13%	99
2021 Q1	$359K	Buy	+59,142	New	+$340K	0.08%	107

Other funds holding ORN

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Invenomic Capital Management's ORN Position: Q3 2022 in Review

Invenomic Capital Management sold out of Orion Group Holdings (ORN) in Q3 2022, closing a stake of 237,871 shares — an estimated $542K sold.

Invenomic Capital Management first reported a position in ORN in Q1 2021 and held it in 6 quarters. The position peaked at $975K in Q4 2021. 51 funds tracked by Wall St. Rank hold ORN as of Q3 2022.

Invenomic Capital Management reported no remaining Orion Group Holdings position as of Q3 2022 after selling out during the quarter.
Invenomic Capital Management sold 237,871 Orion Group Holdings shares in Q3 2022, an estimated $542K.
Invenomic Capital Management first reported a position in Orion Group Holdings in Q1 2021 and held it in 6 quarters.
Invenomic Capital Management's Orion Group Holdings position peaked at $975K in Q4 2021.
51 funds tracked by Wall St. Rank held Orion Group Holdings as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.